Filing Flows

Filing Flows › Profound Medical (PROF) › Who owns the stock

Who owns Profound Medical (PROF) stock

50 funds reported Profound Medical (PROF) shares in their latest 13F filings, worth $103M in all. The largest holder is FIL ($15.8M). Last quarter 15 funds added to their stakes and 19 cut them.

Largest holders of PROF (13F)Largest holders of PROF (13F)FIL$15.8MGagnon Securities LLC$13.0MRoyce & Associates LP$8.0MTimelo Investment Management$7.4MGagnon Advisors, LLC$6.4MFirst Eagle Investment Management…$5.9MRosalind Advisors$5.5MZ3 Capital Partners, LLC$5.5MLetko, Brosseau & Associates$5.4MMmcap International Inc. SPC$4.5M

Largest holders (13F)

FundSharesValueChangeQuarter
FIL2,370,000$15.8Mincrease2026-06-30
Gagnon Securities LLC1,960,074$13.0Mincrease2026-06-30
Royce & Associates LP1,199,564$8.0Mincrease2026-06-30
Timelo Investment Management1,114,967$7.4Munchanged2026-06-30
Gagnon Advisors, LLC962,186$6.4Munchanged2026-06-30
First Eagle Investment Management, LLC880,414$5.9Mincrease2026-06-30
Rosalind Advisors828,118$5.5Munchanged2026-06-30
Z3 Capital Partners, LLC820,941$5.5Mincrease2026-06-30
Letko, Brosseau & Associates935,725$5.4Mdecrease2026-06-30
Mmcap International Inc. SPC671,356$4.5Mdecrease2026-06-30
Ardsley Advisory Partners LP575,000$3.8Munchanged2026-06-30
Lagoda Investment Management, L.P.501,325$3.3Mincrease2026-06-30
Royal Bank of Canada491,495$3.3Mdecrease2026-06-30
Paragon Associates & Paragon Associates II Joint Venture276,001$1.8Mnew2026-03-31
Dafna Capital Management LLC260,360$1.7Mdecrease2026-06-30

Profound Medical's latest quarter

Profound Medical, Q3 2026: revenue $9.8M (+86% year over year), operating margin -79.6%, net loss $7.7M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most PROF stock?

By the latest 13F filings: FIL ($15.8M); Gagnon Securities LLC ($13.0M); Royce & Associates LP ($8.0M); Timelo Investment Management ($7.4M); Gagnon Advisors, LLC ($6.4M).

What is the short interest in PROF?

1,557,966 shares were sold short at the 2026-10-15 settlement, 5.03% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.